AgeX Therapeutics Reports Second Quarter 2021 Financial Results
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (AgeX; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter ended June 30, 2021.
Liquidity…
